Last Updated: January 7, 2026, 9 am UTC
Developing a product from concept to commercialization is a multi-faceted and risky process. Particularly for complex programs, development plans must be customized based on real-world patient experience and optimized for a product’s post-approval success.
A cross-disciplinary team is essential for crafting and assessing complex development programs. These experts should review individually and as a whole the various aspects of the program. Further, experienced advocates with an understanding of patient-centered drug development should identify opportunities to gain the patient perspective at every step of the development process.
In this way, a sponsor can anticipate and reduce development and regulatory risk, control expenses, and optimize speed to market while accounting for the many variables in a development plan:
- Patient population
- Study design
- Enrollment criteria
- Standard of care
- Appropriate endpoints
- Benefit/risk
- Manufacturing timelines
- Patient burden
- Provider agreement
- Expedited approval options
- Relevant guidances
In the end, this early planning allows the sponsor to achieve the Five Rs: Getting the right dose of the right product in the right indication to the right patient at the right time.
